Coffee, Tea Intake and Atrial Fibrillation Risk in UK Biobank

11/16/2026
Key Takeaways
- Among UK Biobank participants initially free of atrial fibrillation, coffee intake was associated with lower incident risk across the reported nonzero intake categories.
- Only the 2–3-cups/day tea category showed a modest inverse association; the other tea categories were not statistically significant.
- Associations for both beverages were nonlinear and do not establish prevention.
Investigators analyzed 495,269 participants without AF at baseline in the UK Biobank prospective study of coffee, tea and atrial fibrillation. Participants separately reported coffee and tea consumption in categories ranging from no intake to several cups daily; no intake was the comparator for each beverage. Cox regression estimated associations between intake and incident AF. Because participants were observed rather than assigned a beverage regimen, the analysis compared existing drinking patterns rather than the effects of changing them.
After adjustment, coffee intake was associated with an estimated 7%–11% lower AF risk than no coffee intake across the reported nonzero categories, with the largest difference at 2–3 cups/day. The middle intake category had the largest observed difference, rather than the highest intake category. These comparisons describe relative associations between groups, not the reduction in risk a person could expect from starting to drink coffee.
During follow-up, 37,261 participants developed AF. Tea intake showed a modest inverse association only at 2–3 cups/day; the other tea categories had no statistically significant association. The patterns for both coffee and tea were nonlinear. Greater reported consumption therefore did not correspond to a steady decline in estimated AF risk across intake categories, and the tea finding should not be extended to every level of consumption.
Beverage intake was self-reported, and this observational analysis cannot establish that consuming coffee or tea prevents AF. People with different drinking habits may also differ in other ways relevant to their later diagnoses. The participants came from a United Kingdom cohort, not a population studied in the United States. The relative associations should not be treated as category-specific absolute benefits or as estimates of what would happen if an individual changed drinking habits.
The authors called for further studies to confirm the associations and clarify potential mechanisms. Whether the beverages themselves or factors accompanying habitual intake account for the observed differences remains unresolved. The findings do not identify a preventive effect that can be attributed to either drink.
Clinician Questions
Can the UK Biobank coffee–atrial fibrillation associations be converted to absolute risk reductions?
No. The coffee comparisons with nondrinkers are relative associations among participants initially free of AF. Category-specific absolute AF risks were not established, so an absolute risk reduction or number needed to treat cannot be calculated from the reported relative differences.
Do the UK Biobank coffee and tea associations identify caffeine as the cause of lower atrial fibrillation risk?
No. Investigators compared self-reported cups of coffee and tea with incident AF, not a verified caffeine-specific causal effect. These beverage-level associations do not identify caffeine as the agent responsible.
This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.
